James Sollins is a private investor and Chairman of Ivy Investment Co., Ltd., a privately held investment company. He currently serves on the boards of directors of Armune BioScience, Inc. and Manchester Copper Tubing, LLC. Sollins was formerly Chairman and CEO of Ivy Animal Health, Inc., a privately held company acquired in 2007 by Eli Lilly and Co., and a member of the Board of Directors of the Animal Health Institute, a trade association of leading companies in the animal health sector of the agricultural industry.
Mr. Sollins was educated as an attorney at the University of Virginia Law School, and also attended the Academy of International Law at The Hague, Netherlands, The London School Of Economics, Yale University, and New York University.
Mr. Sollins currently resides in Dunmore Town, Harbour Island, Bahamas, where he is active in various charitable endeavors, and in New York City, where he serves on the Board of Trustees of Art21 and is a member of the Contemporary Arts Council of the Museum of Modern Art and the Patrons Councils of the Brooklyn Academy of Music (BAM), The Solomon R. Guggenheim Museum, and The New Museum of Contemporary Art.
An avid tennis player and sailor, Mr. Sollins was active in the International One Design Class and raced on several boats that qualified for IOD national and international sailing championships.